BIOSYNTH CARBOSYNTH
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 27 Jan 2026)
What this means for you
Registered since 03 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88530588
- Registration number
- 6000778
- Mark type
- Stylized text
- Filed
- 23 Jul 2019
- Published for opposition
- 17 Dec 2019
- Registered
- 03 Mar 2020
- Attorney of record
- Tara Sliva
Goods and services
- Class 001 — Chemicals: Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
- Class 005 — Pharmaceuticals: Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA)
Owner
- Biosynth AG, Staad, CH
- Biosynth AG, Staad, CH
- Biosynth AG, Staad, CH
Prior registrations
Prosecution history
- 27 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Jan 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 22 Jan 2026 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 22 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Oct 2025 — TEAS SECTION 8 & 15 RECEIVED
- 03 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Aug 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Aug 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 17 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2019 — PUBLISHED FOR OPPOSITION
- 27 Nov 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Nov 2019 — ASSIGNED TO LIE